BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25201622)

  • 1. Surgery: Venous thromboembolism and urological surgery.
    Phillips R
    Nat Rev Urol; 2014 Oct; 11(10):539. PubMed ID: 25201622
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment.
    Goldman HB
    Urology; 2014 Oct; 84(4):806-7. PubMed ID: 25156516
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply: To PMID 25156513.
    Alberts BD; Badani KK
    Urology; 2014 Oct; 84(4):807. PubMed ID: 25156515
    [No Abstract]   [Full Text] [Related]  

  • 4. Postoperative D-dimer predicts venous thromboembolism in patients undergoing urologic tumor surgery.
    Shi A; Huang J; Wang X; Li M; Zhang J; Chen Y; Huang Y
    Urol Oncol; 2018 Jun; 36(6):307.e15-307.e21. PubMed ID: 29599070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, risk profile and morphological pattern of lower extremity venous thromboembolism after urological cancer surgery.
    Clément C; Rossi P; Aissi K; Barthelemy P; Guibert N; Auquier P; Ragni E; Rossi D; Frances Y; Bastide C
    J Urol; 2011 Dec; 186(6):2293-7. PubMed ID: 22014814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended venous thromboembolism prophylaxis after radical pelvic surgery for urological cancers.
    Phillips J; Makarawo T; Abedin A; Shafik A; Eaton J; Makar A
    BJU Int; 2010 Oct; 106(8):1110-1. PubMed ID: 20825399
    [No Abstract]   [Full Text] [Related]  

  • 7. Procedure-specific Risks of Thrombosis and Bleeding in Urological Cancer Surgery: Systematic Review and Meta-analysis.
    Tikkinen KAO; Craigie S; Agarwal A; Violette PD; Novara G; Cartwright R; Naspro R; Siemieniuk RAC; Ali B; Eryuzlu L; Geraci J; Winkup J; Yoo D; Gould MK; Sandset PM; Guyatt GH
    Eur Urol; 2018 Feb; 73(2):242-251. PubMed ID: 28342641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism after major urologic oncology surgery: a focus on the incidence and timing of thromboembolic events after 27,455 operations.
    Alberts BD; Woldu SL; Weinberg AC; Danzig MR; Korets R; Badani KK
    Urology; 2014 Oct; 84(4):799-806. PubMed ID: 25156513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative venous thromboembolism in urologic oncology procedures, risk factors, and prevention.
    Kukreja JEB
    Curr Opin Urol; 2018 May; 28(3):227-232. PubMed ID: 29465471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboprophylaxis in urological cancer surgery.
    Michalski W; Poniatowska G; Jonska-Gmyrek J; Kucharz J; Stelmasiak P; Nietupski K; Ossolinska-Skurczynska K; Sobieszczuk M; Demkow T; Wiechno P
    Med Oncol; 2019 Nov; 37(1):11. PubMed ID: 31768889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of fondaparinux for prevention of postoperative venous thromboembolism in urological malignancy: A prospective randomized clinical trial.
    Hata K; Kimura T; Tsuzuki S; Ishii G; Kido M; Yamamoto T; Sasaki H; Miki J; Yamada H; Furuta A; Miki K; Egawa S
    Int J Urol; 2016 Nov; 23(11):923-928. PubMed ID: 27545448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of extended venous thromboembolism prophylaxis following urologic pelvic surgery.
    Sagalovich D; Say R; Kaouk J; Mehrazin R
    Urol Oncol; 2018 Mar; 36(3):83-87. PubMed ID: 29336977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of extended venous thromboembolism prophylaxis for major urological cancer operations.
    Naik R; Mandal I; Hampson A; Lane T; Adshead J; Rai BP; Vasdev N
    BJU Int; 2019 Dec; 124(6):935-944. PubMed ID: 31468645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of venous thromboembolism after minimally invasive surgery in patients with newly diagnosed endometrial cancer.
    Del Priore G; Hamed AH
    Obstet Gynecol; 2013 Apr; 121(4):876-877. PubMed ID: 23635694
    [No Abstract]   [Full Text] [Related]  

  • 15. Low molecular weight heparin for venous thromboembolism prophylaxis in urologic oncologic surgery.
    Sawczuk IS; Williams D; Chang DT
    Cancer Invest; 2002; 20(7-8):889-92. PubMed ID: 12449719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of extended-duration prophylaxis for venous thromboembolism in major urologic oncology surgery.
    Kukreja JE; Levey HR; Scosyrev E; Kiernan M; Berrondo C; McNamee C; Wu G; Joseph JV; Ghazi A; Rashid H; Dozier A; Messing EM
    Urol Oncol; 2015 Sep; 33(9):387.e7-16. PubMed ID: 25637953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivering better care and value in urological procedures.
    Leow JJ; Trinh QD
    Can J Urol; 2015 Aug; 22(4):7857. PubMed ID: 26267022
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence of, and risk factors for, postoperative venous thromboembolism in patients with benign or malignant musculoskeletal tumors.
    Tsuda Y; Goto T; Ikegami M; Yamada N; Yamakawa K; Hozumi T; Kawano H; Takaki Y; Kitahara Y
    J Orthop Sci; 2013 Jul; 18(4):613-7. PubMed ID: 23674346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of extended thromboprophylaxis in patients undergoing major surgery for cancer.
    Serra R; de Franciscis S
    Thromb Res; 2014 Jun; 133(6):965-6. PubMed ID: 24630644
    [No Abstract]   [Full Text] [Related]  

  • 20. Accurately Measuring Hospital Venous Thromboembolism Prevention Efforts.
    Yang AD; Bilimoria KY
    JAMA; 2016 May; 315(19):2113-4. PubMed ID: 27187304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.